Lessons from the pandemic

10:30 • S3L1 • COVID-19 and Myositis-a relevant problem ? > W. Werner STENZEL (Berlin, Germany) 11:00 • S3L2 • Telemedicine to overcome barriers in NMD- myths and realities > G. Gabriele SICILIANO (Pisa, Italy) 11:30 • S3L3 • Evaluation of anti-SARs-CoV-2 vaccination efficacy in patients with severe neuromuscular diseases > A. Alexia DAMOUR (Bordeaux, France) 11:45 • S3L4 • Safety of COVID-19 vaccination in a large French cohort of neuromuscular patients: data from the VACNEMUS study > M. Marlène BARNAY (Bordeaux, France)